Skip to main content

SI-BONE, Inc.

SIBN
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001459839

In the last 90 days, SI-BONE, Inc. insiders filed 0 open-market purchases and 9 sales; 167 institutions reported holding it in 13F filings for Q2 2026, worth $773.9M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding SI-BONE, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of SIBN: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders149155+6
Shares38.9M39.3M+305.9K (+0.8%)
Value$826.3M$823.7M−$2.62M (−0.3%)

New holders (27)

Institutions that held SI-BONE, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to SIBN in Q4 2023
InstitutionSharesValue% of portfolio
American Century Companies Inc1,179,524$24.8M0.02%
Victory Capital Management Inc320,196$6.72M0.01%
Bellevue Group AG125,200$2.63M0.04%
Jane Street Group, LLC93,717$1.97M0.00%
Balyasny Asset Management LLC77,627$1.63M0.00%
Calamos Advisors LLC29,554$620.3K0.00%
Alpha DNA Investment Management LLC26,495$556.1K0.33%
Mach-1 Financial Group, Inc.23,492$493.1K0.19%
AE Wealth Management LLC23,368$457.3K0.00%
Dynamic Technology Lab Private Ltd19,605$412.0K0.04%
HighMark Wealth Management LLC19,000$398.8K0.29%
Nebula Research & Development LLC14,229$298.7K0.09%
Aquatic Capital Management LLC13,300$279.0K0.01%
Bailard, Inc.12,800$268.7K0.01%
Fox Run Management, L.L.C.12,401$260.3K0.07%
Semanteon Capital Management, LP11,981$251.5K0.17%
XTX Topco Ltd11,354$238.3K0.05%
EntryPoint Capital, LLC7,793$163.6K0.16%
Coppell Advisory Solutions LLC1,525$32.0K0.01%
Quarry LP1,318$27.7K0.01%
Cetera Trust Company, N.A500$10.5K0.01%
Macroview Investment Management LLC356$7.47K0.01%
AJOVista, LLC303$6.36K0.01%
Group One Trading, L.P.170$3.57K0.00%
Principal Securities, Inc.159$3.34K0.00%
Clearstead Advisors, LLC62$1.30K0.00%
Farther Finance Advisors, LLC28$5880.00%

Sold out (21)

Institutions that held SI-BONE, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.